Regenerative Medicine For Cartilage Global Market to Reach $7.03 Billion by 2026 at a CAGR of 7.5%

DUBLIN, Sept. 5, 2022 /PRNewswire/ -- The "Regenerative Medicine For Cartilage Global Market Report 2022: By Treatment, By Treatment, By Site, By Application, By End-Use" report has been added to ResearchAndMarkets.com's offering.

The global regenerative medicine for cartilage market is expected to grow from $4.83 billion in 2021 to $5.26 billion in 2022 at a compound annual growth rate (CAGR) of 9%. The market is expected to reach $7.03 billion in 2026 at a CAGR of 7.5%.

Europe was the largest region in regenerative medicine for cartilage market in 2021. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The growing incidence of osteoarthritis across the globe will drive the market for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that mostly attacks the articular cartilage. According to the Arthritis Foundation in 2019, degenerative joint disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for the market for regenerative medicine for cartilage.

The high cost of regenerative medicine therapies is one of the major factors limiting the growth of the market for regenerative medicine for cartilage. The average cost for knee replacement is around $4,500 to $8,400, while the average cost of cartilage repair procedures is around $18,000, depending on the country where the procedure is being performed. Such high prices discourage individuals to resort to cartilage repair therapies, and in turn, result in a lower preference for these procedures.

Tissue engineering and stem cell therapy are emerging trends in the regenerative medicine for cartilage market. The growth of tissue engineering technology has given hope for the regeneration of cartilage. Stem cell therapy is gaining attention with its advantages over traditional orthopedic treatments. Stem cell therapy helps to reduce knee pain and improves knee cartilage regeneration and repair. For instance, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively. Companies operating in the market are continuously focusing on introducing new technologies to survive in the regenerative medicine for cartilage market.

Scope
Markets Covered:
1) By Treatment Modality: Cell-Based; Non-Cell-Based
2) By Treatment Type: Palliative; Intrinsic Repair Stimulus; Others
3) By Site: Knee Cartilage Repair; Ribs; Others
4) By Application: Hyaline Cartilage Repair and Regeneration; Elastic Cartilage Repair and Regeneration; Fibrous Cartilage Repair and Regeneration
5) By End-Use: Ambulatory Surgical Centers; Hospitals & Clinics; Surgical Centers; Others

Key Topics Covered:

1. Executive Summary

2. Regenerative Medicine For Cartilage Market Characteristics

3. Regenerative Medicine For Cartilage Market Trends And Strategies

4. Impact Of COVID-19 On Regenerative Medicine For Cartilage

5. Regenerative Medicine For Cartilage Market Size And Growth

6. Regenerative Medicine For Cartilage Market Segmentation

7. Regenerative Medicine For Cartilage Market Regional And Country Analysis

8. Asia-Pacific Regenerative Medicine For Cartilage Market

9. China Regenerative Medicine For Cartilage Market

10. India Regenerative Medicine For Cartilage Market

11. Japan Regenerative Medicine For Cartilage Market

12. Australia Regenerative Medicine For Cartilage Market

13. Indonesia Regenerative Medicine For Cartilage Market

14. South Korea Regenerative Medicine For Cartilage Market

15. Western Europe Regenerative Medicine For Cartilage Market

16. UK Regenerative Medicine For Cartilage Market

17. Germany Regenerative Medicine For Cartilage Market

18. France Regenerative Medicine For Cartilage Market

19. Eastern Europe Regenerative Medicine For Cartilage Market

20. Russia Regenerative Medicine For Cartilage Market

21. North America Regenerative Medicine For Cartilage Market

22. USA Regenerative Medicine For Cartilage Market

23. South America Regenerative Medicine For Cartilage Market

24. Brazil Regenerative Medicine For Cartilage Market

25. Middle East Regenerative Medicine For Cartilage Market

26. Africa Regenerative Medicine For Cartilage Market

27. Regenerative Medicine For Cartilage Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Regenerative Medicine For Cartilage Market

29. Regenerative Medicine For Cartilage Market Future Outlook and Potential Analysis

30. Appendix

 Companies Mentioned

  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings inc.
  • Vericel Corporation
  • Stryker Corporation
  • Smith & Nephew plc.
  • Arthrex inc.
  • CONMED Corporation
  • Collagen Solutions plc.
  • BioTissue Technologies
  • CellGenix
  • Osiris Therapeutics inc.
  • DePuy Synthes

For more information about this report visit https://www.researchandmarkets.com/r/78cdi1

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/regenerative-medicine-for-cartilage-global-market-to-reach-7-03-billion-by-2026-at-a-cagr-of-7-5-301617771.html

SOURCE Research and Markets

Posted In: Publishing/Information ServicesPress Releases